With the launch of its first…
With the launch of its first direct-to-patient program, Genentech is [...]
The trials demonstrated the…
The trials demonstrated the benefits of Praxis’ ulixacaltamide in essential [...]
French antibody specialist…
French antibody specialist Adcytherix has added a €105 million ($122 [...]
A Keytruda-based regimen has shown…
A Keytruda-based regimen has shown a statistically significant overall survival [...]
America Is Heavily Reliant on China for Raw Materials in Medicines
A new analysis found that nearly 700 drugs approved for [...]
In separate announcements on…
In separate announcements on Wednesday, a pair of agencies shared [...]
With sales of potential…
With sales of potential blockbuster Lokelma scaling up, AstraZeneca is [...]
Boehringer Ingelheim will pay…
Boehringer Ingelheim will pay AimedBio up to $991 million to [...]
Eli Lilly has guided its oral…
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron [...]
After Omeros decided to hit pause…
After Omeros decided to hit pause on developing its MASP-3 [...]